Skip to Main Content

COVID-19

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.cdc.gov/coronavirus/

Get the latest research information from NIH: https://covid19.nih.gov/

Here you can browse the complete list of publications for studies listed on CDAS.

Studies
Publication Year
Results: 1039 (Showing 1021 to 1039)
Title PubMed Id Authors Journal Abbreviation Year Studies
Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group. 8849769 Auvinen A, Rietbergen JB, Denis LJ, Schröder FH, Prorok PC J Med Screen 1996
Screening and prevention trials step up minority recruitment. 8797765 Reynolds T J. Natl. Cancer Inst. 1996
The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial of the National Cancer Institute. Gohagan JK, Prorok PC, Kramer BS, Hayes RB, Cornett JE Cancer 1995 PLCO
Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. 7523735 Gohagan JK, Prorok PC, Kramer BS, Cornett JE J. Urol. 1994
Screening for prostate cancer 7528519 Gohagan JK, Kramer BS, Greenwald P Am J Prev Med 1994
NIH Consensus 1994: screening. 7835804 Kramer BS, Gohagan J, Prorok PC Gynecol. Oncol. 1994
The National Cancer Institute multi-screening trial. Prorok PC, Gohagan J, Kramer B Canadian J Urol 1994 PLCO
The National Cancer Institute Multi-Screening Trial. 8853500 Prorok P Can J Oncol 1994
A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. 8420681 Kramer BS, Gohagan J, Prorok PC, Smart C Cancer 1993
Prostate cancer screening: what we know and what we need to know. 7692780 Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK Ann. Intern. Med. 1993
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. 8474513 Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F N Engl J Med 1993 MINN
Periodic screening for breast cancer: the Health Insurance Plan Project, 1963 - 1986, and its sequelae. Shapiro S, Venet W, Strax P, Venet L. None 1988
Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. 6091506 Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N Am. Rev. Respir. Dis. 1984 MEM
Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. 6734291 Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N Chest 1984 MEM
Evidence on screening for breast cancer from a randomized trial. 326378 Shapiro S Cancer 1977 HIPB
Impact of efforts to increase participation in repetitive screenings for early breast cancer detection. 5011163 Fink R, Shapiro S, Roester R Am J Public Health 1972 HIPB
Proceedings: Changes in 5-year breast cancer mortality in a breast cancer screening program. 4764931 Shapiro S, Strax P, Venet L, Venet W Proc Natl Cancer Conf 1972 HIPB
The reluctant participant in a breast cancer screening program. 4968124 Fink R, Shapiro S, Lewison J Public Health Rep 1968 HIPB
A Randomized Phase Ii Trial of Low Dose Aspirin Versus Placebo in High-Risk Individuals with CT Screen Detected Subsolid Lung Nodules. Bonanni, B., Serrano, D., Maisonneuve, P., Veronesi, G., Johansson, H., Aristarco, V., … Szabo, E. IEO EPPT